Moderators of two dual eating disorder and obesity prevention programs.
Sign Up to like & getrecommendations! Published in 2019 at "Behaviour research and therapy"
DOI: 10.1016/j.brat.2019.04.002
Abstract: Few trials have investigated factors that moderate the effects of eating disorder and obesity prevention programs, which may inform inclusion criteria and intervention refinements. We examined factors hypothesized to moderate the effects of the Healthy… read more here.
Keywords: eating disorder; obesity prevention; disorder; disorder obesity ... See more keywords
Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor Ameliorate Metabolic Disorder and Obesity Induced Cardiomyocyte Injury and Mitochondrial Remodeling
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24076842
Abstract: Sodium-glucose transporter 2 inhibitors (SGLT2is) exert significant cardiovascular and heart failure benefits in type 2 diabetes mellitus (DM) patients and can help reduce cardiac arrhythmia incidence in clinical practice. However, its effect on regulating cardiomyocyte… read more here.
Keywords: mdo; metabolic disorder; sodium glucose; disorder obesity ... See more keywords